Medicare Enrolled

Dr. Matthew Gold, M.D.

Neurology · Winchester, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
955 MAIN ST, Winchester, MA 01890
7817294344
In practice since 2006 (19 years)
NPI: 1154338028 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gold? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gold

Dr. Matthew Gold is a neurology specialist in Winchester, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gold performed 308 Medicare services across 219 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gold received a total of $9,581 from 48 pharmaceutical and/or device companies across 423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 308 Medicare services $9,581 industry payments

Medicare Practice Summary

Medicare Utilization ↗
308
Medicare services
Bottom 47% in MA for neurology
219
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
90 $27 $125
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
87 $144 $375
New patient office visit, complex (60-74 min) 55 $179 $650
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $99 $275
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
27 $129 $600
Prolonged inpatient or observation care, each additional 15 minutes
This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider.
21 $26 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,581
Total received (2018-2024)
Avg $1,369/year across 7 years
Top 26% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
423
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,469 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$112 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,876
2023
$1,500
2022
$1,557
2021
$1,567
2020
$979
2019
$894
2018
$1,209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Kyowa Kirin, Inc.
$323
ABBVIE INC.
$255
Lundbeck LLC
$234
UCB, Inc.
$188
Eisai Inc.
$158
PFIZER INC.
$154
Amneal Pharmaceuticals LLC
$144
Alexion Pharmaceuticals, Inc.
$113
CATALYST PHARMACEUTICALS, INC.
$77
Lilly USA, LLC
$59
Vanda Pharmaceuticals Inc.
$46
Grifols USA, LLC
$42
Abbott Laboratories
$25
Baxter Healthcare
$22
Teva Pharmaceuticals USA, Inc.
$19
Life Molecular Imaging Ltd
$18
Top 3 companies account for 43.2% of 2024 payments
All-time payments by company (2018-2024) ›
Kyowa Kirin, Inc.
$838
UCB, Inc.
$647
ABBVIE INC.
$633
Novartis Pharmaceuticals Corporation
$609
Lundbeck LLC
$603
Eisai Inc.
$587
Biogen, Inc.
$497
Teva Pharmaceuticals USA, Inc.
$474
Alexion Pharmaceuticals, Inc.
$374
Sunovion Pharmaceuticals Inc.
$371
CATALYST PHARMACEUTICALS, INC.
$272
Celgene Corporation
$264
Amgen Inc.
$262
PFIZER INC.
$248
Amneal Pharmaceuticals LLC
$248
Avanir Pharmaceuticals, Inc.
$247
Biohaven Pharmaceutical Holding Company Ltd.
$192
Grifols USA, LLC
$189
GE Healthcare
$183
Allergan, Inc.
$181
Biohaven Pharmaceuticals, Inc.
$174
AbbVie Inc.
$132
Catalyst Pharmaceuticals, Inc.
$130
Janssen Pharmaceuticals, Inc
$124
Acorda Therapeutics, Inc
$112
GENZYME CORPORATION
$106
Lilly USA, LLC
$104
Bayer HealthCare Pharmaceuticals Inc.
$69
Shire North American Group Inc
$64
EISAI INC.
$57
Allergan Inc.
$56
Baxter Healthcare
$53
Impax Laboratories, Inc.
$53
E.R. Squibb & Sons, L.L.C.
$51
Vanda Pharmaceuticals Inc.
$46
Genentech USA, Inc.
$40
GE HEALTHCARE
$35
Vertical Pharmaceuticals, LLC
$35
Egalet US Inc
$33
Neurocrine Biosciences, Inc.
$32
Upsher-Smith Laboratories LLC
$27
Abbott Laboratories
$25
Boston Scientific Corporation
$21
AstraZeneca Pharmaceuticals LP
$20
Life Molecular Imaging Ltd
$18
Adamas Pharmaceuticals, Inc.
$17
ACADIA Pharmaceuticals Inc
$14
Ultragenyx Pharmaceutical Inc.
$13
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BRILINTA · Betaseron · Briviact · COMIRNATY · COPAXONE · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hillrom - Volara System · INBRIJA · KESIMPTA · KISUNLA · Leqembi · MAYZENT · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONGENTYS · OSMOLEX ER · Ongentys · PAXLOVID · PONVORY · PROCLAIM · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RYTARY · SPRIX · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · Vimpat · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Winchester?
Compare neurologists in the Winchester area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
662
Per 100K population
40.8
County median income
$126,779
Nearest hospital
WINCHESTER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gold is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gold experienced with prolonged office e/m service, first 15 minutes?
Based on Medicare claims data, Dr. Gold performed 90 prolonged office e/m service, first 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gold receive payments from pharmaceutical companies?
Yes. Dr. Gold received a total of $9,581 from 48 companies across 423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gold's costs compare to other neurologists in Winchester?
Dr. Gold's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →